Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up Women only

Diphenhydramine added to standard sedation for first-trimester abortion

Official title: Diphenhydramine as an Adjunct to Moderate Sedation for Procedural First Trimester Abortions

Run by University of Rochester · NCT07542730 · Data updated 2026-11-12

This trial tests whether giving diphenhydramine with standard moderate sedation improves pain control during first-trimester uterine aspiration for adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment98 (estimated)
SponsorUniversity of Rochester
Academic / other
Locations1 site (Rochester, New York)
StatusRecruiting
StartedJune 29, 2026
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedAugust 21, 2026
Trial IDNCT07542730 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18+ undergoing first-trimester uterine aspiration (≤13 weeks) seeking moderate sedation and meeting safety criteria.

Probably not a fit

Those who do not respond to diphenhydramine or have no added pain relief from the adjunct may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, double-blind, randomized, placebo-controlled study at the University of Rochester Family Planning Clinic and Strong Memorial Hospital. Adults undergoing first-trimester uterine aspiration (≤13 weeks) are randomized 1:1 to receive either intravenous diphenhydramine 50 mg or placebo in addition to standard moderate sedation with midazolam and fentanyl. Pain is measured with a 100 mm visual analog scale at multiple peri-procedural time points, and sedation depth is assessed with a sedation scale; additional outcomes include total sedative dose, time to discharge, and adverse events. The goal is to determine if diphenhydramine as an adjunct reduces procedural pain and improves patient experience.

Why it matters

Potential benefit: If successful, patients may experience less pain and smoother recovery during early pregnancy procedures.

How similar studies have gone: Previous work in adjunctive medications for sedation has shown potential benefits in pain control, but this specific diphenhydramine addition is a novel approach within this procedure.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults age 18 years and older
* Desire procedural abortion with moderate sedation
* Gestational age less than or equal to 13 weeks
* Intrauterine pregnancy or pregnancy of unknown location
* Body mass index less than or equal to 40

Exclusion Criteria:

* Desire medical abortion or desire to continue pregnancy
* Gestational age greater than 13 weeks
* Body mass index greater than 40
* Age younger than 18 years
* Confirmed ectopic pregnancy
* Medical condition that is a contraindication to moderate sedation as determined by the treating clinician

Where it's running

  • Gender Wellness OB/GYN
    Rochester, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.